JPRN-UMIN000020331已完成未知
The potential effect of Dapagliflozin on diabetic macular edema - The potential effect of Dapagliflozin on diabetic macular edema
Kyoto Prefectural University of Medicine Department of Endocrinology and Metabolism0 个研究点目标入组 45 人开始时间: 2015年12月24日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 45
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Refusal or lack of capacity to give informed consent The contraindications use of Dapagliflozin History of SGLT2i eGFR <45mL/min/1.73m2 Anti GAD antibody positive Pregnant or current Brest feeding Recent history of cardiovascular events AST and/or ALT > 3x upper limit of normal Total bilirubin > 3.0 mg/d
研究者
相似试验
尚未招募
4 期
Dapagliflozin in Acute Heart failureIRCT20220529055013N1Public Sector medical University160
尚未招募
不适用
Effect of Dapagliflozin for type 2 diabetes mellitus with fatty liverJPRN-UMIN000026549Kagawa prefectural central hospital25
已完成
不适用
Effect of Dapagliflozin in patients with type 2 daibetes mellitusType 2 diabetes mellitusJPRN-UMIN000014922Iwasaki Naika Clinic50
尚未招募
4 期
Assessment of Empagliflozin effects in coronary artery diseaseIRCT20190412043247N2Zanjan University of Medical Sciences100
招募中
1 期
Dapaglifozin use in patients with heart failure during acute myocardial infarctioEUCTR2021-002813-33-ITAZIENDA OSPEDALIERO UNIVERSITARIA MAGGIORE DELLA CARITà DI NOVARA140